# LENMELDY

NDC: 83222-0200
Generic name: atidarsagene autotemcel
Labeler / Manufacturer: Orchard Therapeutics (Europe) Ltd
Product type: CELLULAR THERAPY
Marketing category: Biologic License Application
Dosage form: SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20240426

FDA application: BLA125758

## Active ingredients

- ATIDARSAGENE AUTOTEMCEL: 11800000 1/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83222-0200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83222-0200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b3e307a7-561b-43b6-a784-9cb1dcfc5196